Poseida Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Poseida Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q3 2024.
  • Poseida Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -41.4 %, a 84.9% increase year-over-year.
  • Poseida Therapeutics, Inc. annual Operating Margin for 2023 was -200 %, a 336% decline from 2022.
  • Poseida Therapeutics, Inc. annual Operating Margin for 2022 was -45.9 %, a 89.9% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -41.4 +234 +84.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 -134 -116 -628% Apr 1, 2024 Jun 30, 2024
Q1 2024 -139 -108 -355% Jan 1, 2024 Mar 31, 2024
Q4 2023 -200 -154 -336% Oct 1, 2023 Dec 31, 2023
Q3 2023 -275 Jul 1, 2023 Sep 30, 2023
Q2 2023 -18.4 Apr 1, 2023 Jun 30, 2023
Q1 2023 -30.5 Jan 1, 2023 Mar 31, 2023
Q4 2022 -45.9 Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.